CASTLE BIOSCIENCES, INC. Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount
CASTLE BIOSCIENCES, INC. (CSTL) reported Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount of $2.37 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes
us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount · last filed 2026-02-26
- CASTLE BIOSCIENCES, INC. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2025 was $2.37M, a 55.37% increase from fiscal 2024.
- CASTLE BIOSCIENCES, INC. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2024 was $1.53M, a 64.65% decline from fiscal 2023.
- CASTLE BIOSCIENCES, INC. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2023 was $4.32M, a 30.09% increase from fiscal 2022.
- CASTLE BIOSCIENCES, INC. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2022 was $3.32M.
| Period end | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 12 month |
|---|---|
| 2025-12-31 | $2.37M 10-K · filed 2026-02-26 |
| 2024-12-31 | $1.53M 10-K · filed 2026-02-26 |
| 2023-12-31 | $4.32M 10-K · filed 2026-02-26 |
| 2022-12-31 | $3.32M 10-K · filed 2025-02-27 |
| 2021-12-31 | -$880.00K 10-K · filed 2023-02-28 |
| 2020-12-31 | -$781.00K 10-K · filed 2022-02-28 |
| 2019-12-31 | $65.00K 10-K · filed 2021-03-11 |
| 2018-12-31 | $53.00K 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |